ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2026

Phase I Study of Telisotuzumab Adizutecan (Temab-A, ABBV-400), a Novel c-Met Antibody-Drug Conjugate, in Patients With Late-Line Colorectal Cancer and Advanced Solid Tumors.

Manish R Sharma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.